Summary
Pyruvate kinase is a tetrameric enzyme, of which different isozymes are known (M, K and L). In normal human brain of adults mainly the M4 type is found with little or none of type K4 or the hybrid K3M. In gliomas of adults as well as in children a shift in the synthesis of isozymes of pyruvate kinase occurs from the M-towards the K-type. In these tumours the hybrid K2M2 is not expressed. In gliomas of children only a spur of K2M2 is found. There exists a peculiar difference in isozyme distribution of pyruvate kinase between gliomas on the one hand and neuro-, retino- and medulloblastomas on the other. In the latter group of tumours often the whole isozyme set is observed and in all cases the hybrids K2M2 and KM3 are found. These findings provide enzymological criteria for the discrimination of neuronal tumours from glial-cell tumours.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Imamura K, Noguchi T, Tanaka T (1986) Regulation of isozyme patterns of pyruvate kinase in normal and neoplastic tissues. In: Staal GEJ, van Veelen CWM (eds) Markers of human neuroeotodermal tumors. CRC Press, Boca Raton, pp 191–222
Jakobiec FA, Font RL (1979) Ocular and Orbital Tumors. In: Johannessen JV (ed) Electronmicroscopy in human medicine. Vol 6, Chapter 8, McGraw Hill
Levin MJ, Dalgelen D, Meienhofer MC, Dreyfus JC, Kahn A (1982) Two different species of messenger RNAs specify synthesis of M1 and M2 pyruvate kinase subunits. Biochim Biophys Acta 699: 77–83
Noguchi T, Tanaka T (1982) The M1 and M2 subunits of rat pyruvate kinase are encoded by different RNAs. I Biol Chem 257: 1110–1113
Noguchi T, Inone H, Tanaka T (1986) The M1− and M2−-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing. J Biol Chem 261: 13807–13812
Peters J, Nash HR, Eicher EM, Bulfield G (1981) Polymorphism of kidney pyruvate kinase in the mouse is determined by a gene, PK-3, on chromosome 9. Biochem Genet 19: 757–759
Russel DS, Rubinstein CJ (1977) Pathology of tumours of the nervous system, 4th edn. Edward Arnold Ltd, London
Saheki S, Saheki K, Tanaka T, Tanaka T (1982) Peptide structures of pyruvate kinase isozymes. 2. Origins of types M1 and M2 isozymes suggested from species variations in their peptide maps. Biochim Biophys Acta 704: 494–502
Schapira F (1973) Isozymes and Cancer. Advances Cancer Res 18: 77–153
Van Veelen CWM, Staal GEJ, Verbiest H, Vlug AMC (1977) Alanine inhibition of pyruvate kinase in gliomas and meningiomas. A diagnostic tool in surgery for gliomas? The Lancet 20: 384–385
Van Veelen CWM, Verbiest H, Vlug AMC, Rijksen G, Staal GEJ (1978) Isozymes of pyruvate kinase from human brain, menigiomas and malignant gliomas. Cancer Res 38: 4681–4687
Van Veelen CWM, Verbiest H, Zulch KJ, van Ketel BA, van der Vlist MJM, Vlug AMC, Rijksen G, Staal GEJ (1979) L-a-alanine inhibition of pyruvate kinase from tumors of the human central nervous system. Cancer Res 39: 4263–4269
Van Veelen CWM, Verbiest H, Zulch KJ, van Ketel BA, van der Vlist MJM, Vlug AMC, Rijksen G, Staal GEJ (1982) Pyruvate kinase in human brain tumours. Its significance in the treatment of gliomas. Acta Neurochir (Wien) 61: 145–159
Van Veelen CWM, Staal GEJ (1986) Pyruvate kinase and human brain tumors. In: Markers of human neuro ectodermal tumors (Staal GEJ, van Veelen CWM, eds.) CRC Press, Boca Raton, pp 63–83
Weber G (1977) Enzymology of Cancer Cells. New Engl J Med 296: 541–551
Zülch KJ (1980) Principles of the new WHO classification of brain tumors. Neuro Radiology 19: 59–66
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Veelen, C.W.M., Rijksen, G. & Staal, G.E.J. Discrimination between neuronal and glial cell tumours by pyruvate kinase electrophoresis. Acta neurochir 91, 126–129 (1988). https://doi.org/10.1007/BF01424567
Issue Date:
DOI: https://doi.org/10.1007/BF01424567